Commissioner Califf's Comments On Supplement Testing Trouble NPA
This article was originally published in The Tan Sheet
Executive Summary
NPA notes a 2010 comment that an omega-3 fish oil study "may be a lesson of all this food supplement stuff that we need to test them like drugs.” Senator Hatch asks Califf to reign in FDA's practice of using guidances to impose additional rules.
You may also be interested in...
Supplement NDI Draft Guidance Discussions Snagged On Basic Criteria
FDA’s dietary supplement division is concerned that firms are not submitting NDI notifications in cases where they should be, while industry stakeholders assert the agency needs to clarify the criteria for determining which products should be the subject of notifications and what information is needed.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.